First Time Loading...

Cryosite Ltd
ASX:CTE

Watchlist Manager
Cryosite Ltd Logo
Cryosite Ltd
ASX:CTE
Watchlist
Price: 0.91 AUD 7.06% Market Closed
Updated: May 21, 2024

Intrinsic Value

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. [ Read More ]

The intrinsic value of one CTE stock under the Base Case scenario is 0.63 AUD. Compared to the current market price of 0.91 AUD, Cryosite Ltd is Overvalued by 30%.

Key Points:
CTE Intrinsic Value
Base Case
0.63 AUD
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cryosite Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CTE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Cryosite Ltd

Provide an overview of the primary business activities
of Cryosite Ltd.

What unique competitive advantages
does Cryosite Ltd hold over its rivals?

What risks and challenges
does Cryosite Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cryosite Ltd.

Provide P/S
for Cryosite Ltd.

Provide P/E
for Cryosite Ltd.

Provide P/OCF
for Cryosite Ltd.

Provide P/FCFE
for Cryosite Ltd.

Provide P/B
for Cryosite Ltd.

Provide EV/S
for Cryosite Ltd.

Provide EV/GP
for Cryosite Ltd.

Provide EV/EBITDA
for Cryosite Ltd.

Provide EV/EBIT
for Cryosite Ltd.

Provide EV/OCF
for Cryosite Ltd.

Provide EV/FCFF
for Cryosite Ltd.

Provide EV/IC
for Cryosite Ltd.

Compare the intrinsic valuations
of Cryosite Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cryosite Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cryosite Ltd compared to its peers.

Compare the P/E ratios
of Cryosite Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Cryosite Ltd with its peers.

Analyze the financial leverage
of Cryosite Ltd compared to its main competitors.

Show all profitability ratios
for Cryosite Ltd.

Provide ROE
for Cryosite Ltd.

Provide ROA
for Cryosite Ltd.

Provide ROIC
for Cryosite Ltd.

Provide ROCE
for Cryosite Ltd.

Provide Gross Margin
for Cryosite Ltd.

Provide Operating Margin
for Cryosite Ltd.

Provide Net Margin
for Cryosite Ltd.

Provide FCF Margin
for Cryosite Ltd.

Show all solvency ratios
for Cryosite Ltd.

Provide D/E Ratio
for Cryosite Ltd.

Provide D/A Ratio
for Cryosite Ltd.

Provide Interest Coverage Ratio
for Cryosite Ltd.

Provide Altman Z-Score Ratio
for Cryosite Ltd.

Provide Quick Ratio
for Cryosite Ltd.

Provide Current Ratio
for Cryosite Ltd.

Provide Cash Ratio
for Cryosite Ltd.

What is the historical Revenue growth
over the last 5 years for Cryosite Ltd?

What is the historical Net Income growth
over the last 5 years for Cryosite Ltd?

What is the current Free Cash Flow
of Cryosite Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cryosite Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cryosite Ltd

Current Assets 9.4m
Cash & Short-Term Investments 5.9m
Receivables 2m
Other Current Assets 1.5m
Non-Current Assets 12.8m
PP&E 3.9m
Intangibles 6k
Other Non-Current Assets 8.9m
Current Liabilities 4.1m
Accounts Payable 1.3m
Accrued Liabilities 266k
Other Current Liabilities 2.5m
Non-Current Liabilities 15.2m
Long-Term Debt 2.4m
Other Non-Current Liabilities 12.9m
Efficiency

Earnings Waterfall
Cryosite Ltd

Revenue
12.6m AUD
Cost of Revenue
-4.9m AUD
Gross Profit
7.7m AUD
Operating Expenses
-5.9m AUD
Operating Income
1.7m AUD
Other Expenses
-168.1k AUD
Net Income
1.6m AUD

Free Cash Flow Analysis
Cryosite Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CTE Profitability Score
Profitability Due Diligence

Cryosite Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
ROE is Increasing
67/100
Profitability
Score

Cryosite Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

CTE Solvency Score
Solvency Due Diligence

Cryosite Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Low D/E
Long-Term Solvency
54/100
Solvency
Score

Cryosite Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTE Price Targets Summary
Cryosite Ltd

There are no price targets for CTE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Cryosite Ltd

Shareholder Return

CTE Price
Cryosite Ltd

1M 1M
+12%
6M 6M
+41%
1Y 1Y
+23%
3Y 3Y
+156%
5Y 5Y
+2 780%
10Y 10Y
+164%
Annual Price Range
0.91
52w Low
0.515
52w High
0.91
Price Metrics
Average Annual Return 196.55%
Standard Deviation of Annual Returns 300.22%
Max Drawdown
N/A
Shares Statistics
Market Capitalization 44.4m AUD
Shares Outstanding 48 809 563
Percentage of Shares Shorted
N/A

CTE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Cryosite Ltd Logo
Cryosite Ltd

Country

Australia

Industry

Life Sciences Tools & Services

Market Cap

44.4m AUD

Dividend Yield

7.15%

Description

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.

Contact

NEW SOUTH WALES
Sydney
13a Ferndell St, South granville
+61288652000.0
https://cryosite.com

IPO

2002-05-09

Employees

-

Officers

Chief Financial Officer
Ms. Jane Hao
Operations Manager
Mr. Jon Stearns
Chief Quality Officer
Ms. Alicia Steel
Company Secretary
Mr. Dray Andrea

See Also

Discover More
What is the Intrinsic Value of one CTE stock?

The intrinsic value of one CTE stock under the Base Case scenario is 0.63 AUD.

Is CTE stock undervalued or overvalued?

Compared to the current market price of 0.91 AUD, Cryosite Ltd is Overvalued by 30%.